Gene expression profiling in a mouse model of Helicobacter-induced gastric cancer

Cancer Science

Volumn 98, Issue 3, 2007, Pages 284-293

  Takaishi, Shigeo ^a   Wang, Timothy C ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); AMPHIREGULIN; APOLIPOPROTEIN A1; CHITINASE; CLAUDIN 7; COLLAGENASE 3; COMPLEMENTARY DNA; COMPLEMENTARY RNA; GALECTIN 2; INTRINSIC FACTOR; SOMATOSTATIN; STROMELYSIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DNA MICROARRAY; DOWN REGULATION; ENZYME SUBUNIT; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENETIC CODE; GROUPS BY AGE; HELICOBACTER FELIS; HELICOBACTER INFECTION; HYPERGASTRINEMIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; STRAIN DIFFERENCE; STROMA CELL; TRANSGENIC MOUSE; UPREGULATION; VALIDATION PROCESS;

ANIMALS; BLOTTING, NORTHERN; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; HELICOBACTER FELIS; HELICOBACTER INFECTIONS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STOMACH NEOPLASMS;

EID: 33846673760     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00392.x     Document Type: Article

References (43)

1. Helicabacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-53.
2. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
3. International Agency for Research on Cancer. 'Infection with Helicobacter pylori'. IARC monographs on the evaluation of the carcinogenic risks Ho humans. 1994; 61: 177. Available from URL: http://193.51.164.11/htdocs/monographs/vol61/m61-3.htm.
4. Houghton J, Fox JG, Wang TC. Gastric cancer: Laboratory bench to clinic. J Gastroenterol Hepatol 2002; 17: 495-502.
5. Fox JG, Beck P, Dangler CA et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 2000; 6: 536-42.
6. Wang TC, Dangler CA, Chen D et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118: 36-47.
7. Kanda N, Seno H, Kawada M et al. Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice. Am J Physiol Gastrointest Liver Physiol 2005; 290: G519-27.
8. Miyaji M, Ogoshi K, Tajima T, Mitomi T. Association between serum gastrin levels, gastric acid secretion and age in early gastric cancer. Tumour Biol 1997; 18: 311-20.
9. Takaishi S, Cui G, Frederick DM et al. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology 2005; 128: 1965-83.
10. Hasegawa S, Furukawa Y, Li M et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23 040 genes. Cancer Res 2002; 62: 7012-7.
11. Hippo Y, Taniguchi H, Tsutsumi S et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 2002; 62: 233-40.
12. Abe M, Yamashita S, Kuramoto T et al. Global expression analysis of N-methyl-N-nitro-N-nitrosoguanidine-induced rat stomach carcinomas using oligonucleotide microarrays. Carcinogenesis 2003; 24: 861-7.
13. Nomura S, Baxter T, Yamaguchi H et al. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. Gastroenterology 2004; 127: 582-94.
14. Maeda S, Otsuka M, Hirata Y et al. cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells. Biochem Biophys Res Commun 2001; 284: 443-9.
15. Fox JG, Wang TC, Rogers AB et al. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 2003; 124: 1879-90.
16. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
17. Kinoshita Y, Ishihara S, Kadowaki Y, Fukui H, Chiba T. Reg protein is a unique growth factor of gastric mucosal cells. J Gastroenterol 2004; 39: 507-13.
18. Sekikawa A, Fukui H, Fujii S et al. REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology 2005; 128: 642-53.
19. Kitadai Y, Yasui W, Yokozaki H et al. Expression of amphiregulin, a novel gene of the epidermal growth factor family, in human gastric carcinomas. Jpn J Cancer Res 1993; 84: 879-84.
20. Tsutsui S, Shinomura Y, Higashiyama S et al. Induction of heparin binding epidermal growth factor-like growth factor and amphiregulin mRNAs by gastrin in the rat stomach. Biochem Biophys Res Commun 1997; 235: 520-3.
21. Tuccillo C, Manzo BA, Nardone G et al. Up-regulation of heparin binding epidermal growth factor-like growth factor and amphiregulin expression in Helicobacter pylori-infected human gastric mucosa. Dig Liver Dis 2002; 34: 498-505.
22. Schiemann U, Konturek JW, Osterhoff M et al. Decreased expression of epidermal growth factor receptor and mRNA of its ligands in Helicobacter pylori-infected gastric mucosa. Scand J Gastroenterol 2001; 36: 23-31.
23. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
24. Aung PP, Oue N, Mitani Y et al. Systematic search for gastric cancer-specific genes based on SAGE data: Melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 2005.
25. Elnemr A, Yonemura Y, Bandou E et al. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Gastric Cancer 2003; 6: 30-8.
26. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 285-93.
27. Kominsky SL, Argani P, Korz D et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003; 22: 2021-33.
28. Al Moustafa AE, Alaoui-Jamali MA, Batist G et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002; 21: 2634-40.
29. Johnson AH, Frierson HF, Zaika A et al. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol 2005; 167: 577-84.
30. Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992; 7: 501-12.
31. Jensen BV, Johansen JS, Price PA. High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin Cancer Res 2003; 9: 4423-34.
32. Cintin C, Johansen JS, Christensen IJ, Price PA, Sorensen S, Nielsen HJ. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 2002; 95: 267-74.
33. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process -First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-40.
34. Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL. Hypergastrinemia in response to gastric inflammation suppresses somatostatin. Am J Physiol Gastrointest Liver Physiol 2002; 282: G175-83.
35. Graham DY, Lew GM, Lechago J. Antral G-cell and D-cell numbers in Helicobacter pylori infection: Effect of H. pylori eradication. Gastroenterology 1993; 104: 1655-60.
36. Lee JY, Eom EM, Kim DS, Ha-Lee YM, Lee DH. Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE. Genomics 2003; 82: 78-85.
37. Kokkola A, Sjoblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Jarvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol 1998; 33: 88-92.
38. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005; 5: 29-41.
39. Oka T, Murakami S, Arata Y et al. Identification and cloning of rat galectin-2: Expression is predominantly in epithelial cells of the stomach. Arch Biochem Biophys 1999; 361: 195-201.
40. Ryu JW, Kim HJ, Lee YS et al. The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 2003; 18: 505-9.
41. Cui G, Takaishi S, Ai W et al. Gastrin-induced apoptosis contributes to carcinogenesis in the stomach. Lab Invest 2006; 86: 1037-51.
42. Tatematsu M, Tsukamoto T, Inada K. Stem cells and gastric cancer: Role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 2003; 94: 135-41.
43. Chiba T, Seno H, Marusawa H et al. Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol 2006; 41: 1-9.